Stocksigma LogoStocksigma Logo

Mankind Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 4,338 (+17.3% YoY | +7.6% QoQ) ■ EBITDA: 1,171 (+27.1% YoY | +10.9% QoQ) ■ EBITDA Margin (%): 27.0 (+208 bps YoY | +80 bps QoQ) ■ PAT: 711

Mankind Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Mankind Pharma Ltd · Outcome · 26 Oct 2026, 8:37 pm

Mankind Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 4,338 (+17.3% YoY | +7.6% QoQ) ■ EBITDA: 1,171 (+27.1% YoY | +10.9% QoQ) ■ EBITDA Margin (%): 27.0 (+208 bps YoY | +80 bps QoQ) ■ PAT: 711 (+39.1% YoY | +25.2% QoQ) ■ EPS (INR): 17.2 (+38.9% YoY | +25.2% QoQ)

Original exchange filing (PDF)

More announcements from Mankind Pharma Ltd

All Mankind Pharma Ltd announcements